These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 18826517)

  • 1. Melanoma associated spongiform scleropathy: characterization, biochemical and immunohistochemical studies.
    Alyahya GA
    Acta Ophthalmol; 2008 Oct; 86 Thesis 3():1-21. PubMed ID: 18826517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinase-2 is expressed in melanoma-associated spongiform scleropathy.
    Alyahya GA; Kolko M; Prause JU; Nielsen BS; Wang J; Heegaard S
    Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):2806-11. PubMed ID: 18579756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melanoma-associated spongiform scleropathy: biochemical changes and possible relation to tumour extension.
    Alyahya GA; Ribel-Madsen SM; Heegaard S; Prause JU; Trier K
    Acta Ophthalmol Scand; 2003 Dec; 81(6):625-9. PubMed ID: 14641266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of melanoma associated spongiform scleropathy.
    Alyahya GA; Heegaard S; Prause JU
    Acta Ophthalmol Scand; 2002 Jun; 80(3):322-6. PubMed ID: 12059874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and distribution of MMPs and TIMPs in human uveal melanoma.
    Lai K; Conway RM; Crouch R; Jager MJ; Madigan MC
    Exp Eye Res; 2008 Jun; 86(6):936-41. PubMed ID: 18423620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of matrix metalloproteinases in vivo in scleritis tissue and in vitro in cultured human scleral fibroblasts.
    Di Girolamo N; Lloyd A; McCluskey P; Filipic M; Wakefield D
    Am J Pathol; 1997 Feb; 150(2):653-66. PubMed ID: 9033278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infiltrating macrophages in extratumoural tissues after brachytherapy of uveal melanoma.
    Toivonen P; Kivelä T
    Acta Ophthalmol; 2012 Jun; 90(4):341-9. PubMed ID: 20809904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinase-2 (MMP-2) immunoreactive protein--a new prognostic marker in uveal melanoma?
    Väisänen A; Kallioinen M; von Dickhoff K; Laatikainen L; Höyhtyä M; Turpeenniemi-Hujanen T
    J Pathol; 1999 May; 188(1):56-62. PubMed ID: 10398141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors for survival after enucleation for choroidal and ciliary body melanomas.
    Isager P; Ehlers N; Overgaard J
    Acta Ophthalmol Scand; 2004 Oct; 82(5):517-25. PubMed ID: 15453846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corneoscleral necrosis after episcleral Au-198 brachytherapy of uveal melanoma.
    Chaudhry IA; Liu M; Shamsi FA; Arat YO; Shetlar DJ; Boniuk M
    Retina; 2009 Jan; 29(1):73-9. PubMed ID: 18728617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cripto-1 expression in uveal melanoma: an immunohistochemical study.
    Mallikarjuna K; Vaijayanthi P; Krishnakumar S
    Exp Eye Res; 2007 Jun; 84(6):1060-6. PubMed ID: 17412323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI for the evaluation of scleral invasion and extrascleral extension of uveal melanomas.
    Récsán Z; Karlinger K; Fodor M; Zalatnai A; Papp M; Salacz G
    Clin Radiol; 2002 May; 57(5):371-6. PubMed ID: 12014934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of vascular endothelial growth factor a, matrix metalloproteinase 9 and extravascular matrix patterns in iris and ciliary body melanomas.
    Sahin A; Kiratli H; Tezel GG; Soylemezoglu F; Bilgic S
    Ophthalmic Res; 2007; 39(1):40-4. PubMed ID: 17164576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CNS metastasis from malignant uveal melanoma: a clinical and histopathological characterisation.
    Holfort SK; Lindegaard J; Isager P; Prause JU; Heegaard S
    Br J Ophthalmol; 2009 May; 93(5):641-4. PubMed ID: 19091854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rationale for implant insertion after enucleation of eyes with uveal melanoma].
    Stoiukhina AS
    Vestn Oftalmol; 2011; 127(1):29-32. PubMed ID: 21539101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scleral patch grafts in the management of uveal and ocular surface tumors.
    Barman M; Finger PT; Milman T
    Ophthalmology; 2012 Dec; 119(12):2631-6. PubMed ID: 22858126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Routes of extraocular extension of uveal melanoma: risk factors and influence on survival probability.
    Coupland SE; Campbell I; Damato B
    Ophthalmology; 2008 Oct; 115(10):1778-85. PubMed ID: 18554722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
    Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
    J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Block resection with scleral flap rotation in ciliary body melanoma].
    Romanowska-Dixon B
    Klin Oczna; 2005; 107(10-12):681-3. PubMed ID: 16619819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The in vivo modulatory effects of an anterior-chamber microenvironment on uveal melanoma.
    Mudhar HS; Saunders E; Rundle P; Rennie IG; Sisley K
    Br J Ophthalmol; 2009 Apr; 93(4):535-40. PubMed ID: 19019926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.